Skip to main content
. 2008 Jun 20;295(2):H728–H735. doi: 10.1152/ajpheart.00022.2008

Fig. 7.

Fig. 7.

Release of CGRP and substance P (SP) from isolated hearts subjected to OLDA (2 × 10−9 M) in the presence or absence of the protein kinase C (PKC) inhibitor chelerythrine (5 × 10−6 M) or the nonselective K+ channel antagonist TBA (5 × 10−4 M). WT and TRPV1−/− are the normal control groups. Values are means ± SE; n = 4. P < 0.05 vs. WT (*) and vs. OLDA-WT (†).